Eli Lilly to seek approval for new obesity drug after successful trials | Retatrutide News

Eli Lilly plans to file for approval of a new obesity drug by 2027 after completing two trials. This marks progress in their GLP-1 drug development pipe...
Market News · October 9, 2026